Ticker Symbol: RNGUF
Regeneus Ltd
Exchange: US OTC
Country:
AU
Currency:
USD
Asset
Type: Common Stock
Company Profile
Regeneus Ltd. is regenerative medicine company. It develops and commercializes innovative cell-based therapies to address unmet medical needs in human and veterinary health. The company was founded by Ben Herbert and Graham Vesey on August 14, 2007 and is headquartered in Pymble, Australia.
Sector: Health Technology
Industry: Biotechnology
Standard Industrial Classification Code (SIC code): 2833
Address: 2 Paddington Street
Website: http://regeneus.com.au
CEO: Karolis Rosickas
Tags:
- Health Technology
- Biotechnology
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-
(
0.00%)
Days Range: - - -
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.00%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 306436914
Valuation
Market Cap: -
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A